Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-03

FDA Approved: POLYETHYLENE GLYCOL — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for polyethylene glycol 3350 by BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene glycol 3350 (polyethylene glycol 3350)

Snippet

SUPPL AP for POLYETHYLENE GLYCOL (POLYETHYLENE GLYCOL)